Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden · Delayed Price · Currency is SEK 12.55
-0.25 (-1.95%)
Aug 13, 2026, 3:45 PM CET
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 88.59 million as of August 13, 2026. Its market cap has decreased by -55.50% in one year.
Market Cap
88.59M
Enterprise Value
71.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.55
ChartMarket Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 88.59M, an increase of 76.44%. That is a compound annual growth rate of 6.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 88.59M | -36.62% |
| Dec 30, 2025 | 139.77M | -39.44% |
| Dec 30, 2024 | 230.78M | 161.10% |
| Dec 29, 2023 | 88.39M | -42.68% |
| Dec 30, 2022 | 154.19M | 12.35% |
| Dec 30, 2021 | 137.24M | 9.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanologica AB | 148.93M |
| Simris Group AB (PUBL) | 146.45M |
| Active Biotech AB | 142.35M |
| NextCell Pharma AB | 135.49M |
| OncoZenge AB | 80.78M |
| Ascelia Pharma AB | 76.12M |
| Spago Nanomedical AB | 76.08M |
| AcouSort AB | 73.02M |